Clinical trials · Baltimore, MD
COPD clinical trials in Baltimore
We’re tracking 19 recruiting copd studies with a site in or near Baltimore — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Baltimore
- NCT06751537Recruiting
Testing a wearable device for COPD severity
This trial tests a wearable device (WearME) that tracks your breathing and activity to see how well it can measure COPD severity. It may help you and your doctor better understand your lung function at home.
Baltimore, MarylandAges 21–100 - NCT06878261RecruitingPhase 3
Tezepelumab for moderate to very severe COPD
This study tests a new medication called tezepelumab (given as a shot) to see if it can reduce COPD flare-ups in people with moderate to very severe COPD who have had recent flare-ups despite using inhalers. It may be an option for those with higher levels of eosinophils (a type of white blood cell) in their blood.
Baltimore, MarylandAges 40–80 - NCT05204888Recruiting
Home breathing device study for COPD patients after recent flare-up
This study tests whether a home high-flow nasal breathing device (myAirvo 3) helps people with COPD who recently needed hospital care for a flare-up. You would use the device at home and track symptoms, oxygen levels, and heart rate daily to see how well it works.
Baltimore, MarylandAges 30 years+ - NCT05033990Recruiting
Study of early COPD changes using breathing tests and scans
This study follows people with early COPD patterns (or no lung disease) to understand how COPD starts and progresses over time. You may have breathing tests and possibly CT scans, and some participants may join an added lung procedure (bronchoscopy).
Baltimore, MarylandAges 30–55 - NCT07059091RecruitingPhase 2
Omalizumab for COPD with allergies
This trial tests if omalizumab, an allergy medication, can help people with COPD who have allergies to common indoor triggers like cat, dog, mouse, cockroach, or dust mite. It aims to reduce flare-ups and improve breathing.
Baltimore, MarylandAges 40 years+ - NCT07082738RecruitingPhase 2
Study of AZD6793 for people with moderate to very severe COPD
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
Baltimore, MarylandAges 40 years+ - NCT05265299RecruitingPhase 3
Testing the right aspirin dose for COPD symptoms
This Phase 3 trial studies which aspirin dose works best in people with COPD, with the goal of improving disease control. You may be asked to take aspirin and be monitored for safety, especially bleeding risk and heart/brain history.
Baltimore, MarylandAges 40–80 - NCT04930289Enrolling by invitation
Lung transplant registry for better donor lung preservation
This study builds a worldwide database to track and improve how donor lungs are preserved before transplant. Your information may help doctors choose and manage donor lungs more effectively.
Baltimore, MarylandAges Any age - NCT06883305RecruitingPhase 3
Testing tezepelumab for moderate to severe COPD
This trial tests tezepelumab, an injected medication, for people with moderate to very severe COPD who still have flare-ups despite using standard inhalers. It may help reduce flare-ups and improve breathing for those with higher eosinophil levels.
Baltimore, MarylandAges 40–80 - NCT05297279Recruiting
Omega-3 diet program for people with COPD
This trial tests whether increasing omega-3 (from diet and/or supplements) helps people with COPD. It enrolls people with low omega-3 intake and asks them to follow a specific dietary plan during the study.
Baltimore, MarylandAges 40 years+ - NCT06376994RecruitingPhase 3
Clean air study for COPD
This study tests if using air cleaners at home improves lung health in people with COPD. If you qualify, you may get an air cleaner for your home and be followed for 12 months.
Baltimore, MarylandAges 40 years+ - NCT06283966RecruitingPhase 3
Triple inhaler for COPD with heart risk
This study tests a triple-combination inhaler (budesonide, glycopyrronium, and formoterol) to see if it can help protect the heart and lungs in people with COPD who also have heart problems or high risk for them.
Glen Burnie, MarylandAges 40–80 - NCT07610395RecruitingPhase 2
Testing an oral drug for cold virus in COPD patients
This trial tests an oral medication (VPV) to see if it can safely treat rhinovirus (a common cold virus) in people with COPD. The goal is to help you recover faster and prevent serious COPD flare-ups.
Lutherville, MarylandAges 40–85 - NCT06961214RecruitingPhase 3
Testing a new biologic for COPD with type 2 inflammation
This trial tests a medicine called depemokimab for people with COPD and a specific type of inflammation (type 2). It aims to see if it can reduce flare-ups when added to standard inhaler therapy.
Rockville, MarylandAges 40–80 - NCT07190222RecruitingPhase 3
New medicine for COPD with frequent flare-ups
This study tests a new medicine called Lunsekimig for people with COPD that has frequent flare-ups and high eosinophil levels (a sign of inflammation). It aims to see if it can help control symptoms better than a placebo (a dummy treatment).
Washington D.C., District of ColumbiaAges 40–80 - NCT01822834Recruiting
Registry for adults with bronchiectasis and non-tuberculosis lung bacteria
This study is a registry that collects health information from adults who have bronchiectasis caused by non-tuberculosis mycobacteria (NTM). It helps researchers better understand this condition and improve future treatments.
Washington D.C., District of ColumbiaAges 18–120 - NCT02803242Recruiting
Patient research network for people with lung symptoms
This trial enrolls adults to help build a patient-powered research network for chronic lung disease. If you join, you’ll likely be asked to complete surveys or provide information to help researchers learn how symptoms and health outcomes change over time.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06035120Recruiting
Sealing damaged lung parts in severe emphysema
This trial tests a new treatment called AeriSeal to seal off damaged parts of the lung in people with severe emphysema. It aims to help you breathe better by reducing the amount of air trapped in your lungs.
Falls Church, VirginiaAges 40–80 - NCT06891755Recruiting
Lung deflation procedure for severe emphysema
This study tests a bronchoscopic treatment to release trapped air in severely hyperinflated lungs caused by emphysema. It may help you breathe easier if you have advanced COPD and meet specific lung function and imaging criteria.
Falls Church, VirginiaAges 40–84
Hear when a new COPD trial opens near Baltimore, MD
We’ll email you when one opens near Baltimore, MD — at most once a week, no account needed, unsubscribe anytime.
COPD trials in other cities
Where these studies are running near Baltimore
Institutions with a site for the recruiting copd studies listed above.
- Johns Hopkins University · 4 studies
- Research Site · 4 studies
- COPD Foundation · 2 studies
- Inova Fairfax Medical Campus · 2 studies
- Johns Hopkins Bayview Medical Center · 2 studies
- Children's National Medical Center
- GSK Investigational Site
- Howard University Hospital
What taking part in a copd study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting copd studies in Maryland.
Common questions
- Are there copd clinical trials near Baltimore?
- Yes. We're currently tracking 19 recruiting copd studies with a site near Baltimore, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a copd study near Baltimore?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Baltimore to take part?
- Not necessarily. These studies have a site near Baltimore, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a copd trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New copd studies open near Baltimore regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.